Darren Cline

2017

In 2017, Darren Cline earned a total compensation of $2.4M as Former Executive Vice President, Commercial at Seattle Genetics, a 16% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$222,834
Option Awards$814,060
Salary$453,108
Stock Awards$888,290
Other$16,709
Total$2,395,001

Cline received $888.3K in stock awards, accounting for 37% of the total pay in 2017.

Cline also received $222.8K in non-equity incentive plan, $814.1K in option awards, $453.1K in salary and $16.7K in other compensation.

Rankings

In 2017, Darren Cline's compensation ranked 4,648th out of 14,666 executives tracked by ExecPay. In other words, Cline earned more than 68.3% of executives.

ClassificationRankingPercentile
All
4,648
out of 14,666
68th
Division
Manufacturing
1,636
out of 5,770
72nd
Major group
Chemicals And Allied Products
476
out of 2,074
77th
Industry group
Drugs
368
out of 1,730
79th
Industry
Biological Products, Except Diagnostic Substances
69
out of 316
78th
Source: SEC filing on April 4, 2019.

Cline's colleagues

We found seven more compensation records of executives who worked with Darren Cline at Seattle Genetics in 2017.

2017

Clay Siegall

Seattle Genetics

Chief Executive Officer

2017

Eric Dobmeier

Seattle Genetics

Chief Operating Officer

2017

Jonathan Drachman

Seattle Genetics

Chief Medical Officer

2017

Todd Simpson

Seattle Genetics

Chief Financial Officer

2017

Vaughn Himes

Seattle Genetics

Chief Technical Officer

2017

Jean Liu

Seattle Genetics

General Counsel

2017

Jean Liu

Seattle Genetics

General Counsel

News

You may also like